# Trial on the Effect of Adalimumab on Vascular Inflammation in Patients With Psoriasis

Study · id `cardio:ct-nct01722214` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01722214](<https://clinicaltrials.gov/study/NCT01722214>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01722214

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 107 participants.

## Technical summary

Registry record NCT01722214. Randomized; triple masking; primary purpose prevention. Start 2012-11 (registry gives no type); primary completion 2015-12 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 107 participants (enrolled count; ClinicalTrials.gov record NCT01722214, source copy `cardio:ctgov-nct01722214-2016-09-09`, retrieved 2026-10-26)
- Start date: 2012-11 (registry gives no type) (ClinicalTrials.gov record NCT01722214, source copy `cardio:ctgov-nct01722214-2016-09-09`, retrieved 2026-10-26)
- Primary completion: 2015-12 (actual) (ClinicalTrials.gov record NCT01722214, source copy `cardio:ctgov-nct01722214-2016-09-09`, retrieved 2026-10-26)
- Completion: 2016-01 (actual) (ClinicalTrials.gov record NCT01722214, source copy `cardio:ctgov-nct01722214-2016-09-09`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT01722214, source copy `cardio:ctgov-nct01722214-2016-09-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01722214-2016-09-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: Trial on the Effect of Adalimumab on Vascular Inflammation in Patients With Psoriasis
- Condition: Psoriasis
- Condition: Vascular Inflammation
- Condition: Coronary Atherosclerosis
- Intervention (Biological): Adalimumab
- Intervention (Other): Placebo
- Lead sponsor: Innovaderm Research Inc.
- Lead sponsor class: OTHER
- Collaborator: Abbott
- Collaborator class: INDUSTRY
- Collaborator: Montreal Heart Institute
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as a collaborator: Abbott (`cardio:abbott`)
- Registry lists this organization as a collaborator: Montreal Heart Institute (`cardio:org-montreal-heart-institute`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: TNF-α Antagonist and Vascular Inflammation in Patients with Psoriasis Vulgaris: A Randomized Placebo-Controlled Study (`cardio:pubmed-28286061`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 4959c083ed961ec6accd3180dfec1dcecdf2a12c78b77da11357882bcf96986f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
